Robert Waltermire

Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals

Dr. Waltermire brings proven expertise in all aspects of chemistry, manufacturing and control (CMC), as well as experience in manufacturing new commercial products. Most recently, Dr. Waltermire served as Senior Vice President, CMC at VenatoRx. From 1988 to 2020, Dr. Waltermire held positions of increasing responsibility at Bristol-Myers Squibb (BMS) and Dupont Pharmaceutical Company, including Vice President Chemical and Synthetic Development at BMS.

Links

Previous companies

Bristol-Myers Squibb logo
Palatin Technologies logo

Org chart

Timeline

  • Chief Pharmaceutical Development Officer

    August, 2021 - present

View in org chart